Position in RMTI
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$38,144
-$23,912 QoQ
Shares Held
6,935
-0.5% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 36 holders
Holding Since
Sep 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RMTI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PANAGORA ASSET MANAGEMENT INC holds $63,112,823 across 13 Drug Manufacturers - Specialty & Generic names. RMTI ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
|
765,543 | $40,114,453 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
443,647 | $7,679,529 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
216,960 | $5,339,385 | |
| 4 | EBS |
Emergent BioSolutions Inc.
|
329,060 | $2,757,522 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
227,579 | $1,802,425 | |
| 6 | ZTS |
Zoetis Inc.
|
22,499 | $1,616,778 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
2,880 | $1,560,470 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,763 | $635,690 |
All Filings in RMTI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,144 | 69,353 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $62,056 | 69,726 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $55,833 | 67,269 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $82,274 | 68,562 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $41,138 | 48,398 | Shares | Sole | 2025-08-13 | |
| 2020-12-31 | $1,151 | 1,140 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,219 | 1,140 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||